Nandrolone-Induced Tumor Progression in Hormone-Sensitive Prostate Cancer.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 35044958.
- Also identified by DOI 10.1097/RLU.0000000000004058.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hormone-sensitive prostate cancer responds favorably to testosterone suppression induced by GnRH analogs or antagonists. This effect may theoretically be countered by anabolic steroids. We describe a patient of a recurrent hormone-sensitive prostate cancer who was on salvage androgen deprivation therapy with degarelix and developed rapid progression after over-the-counter nandrolone injections.
Medical subject headings
- Nandrolone
- Prostatic Neoplasms